Home / Inspections / 1198613

FDA Inspection 1198613 — Lilly del Caribe, Inc.

Lilly del Caribe, Inc. — FEI 3004525072

The FDA completed an inspection of Lilly del Caribe, Inc. on February 17, 2023 in Carolina, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 17, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Carolina, PR (United States)

Facility

Other inspections at this facility

  • 1321482 (NAI Tue May 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1069980 (NAI Thu Sep 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 974723 (VAI Wed Jun 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 868382 (NAI Fri Feb 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 776200 (VAI Wed Apr 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources